Nasdaq
Shares out 2.3M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
5- 9.23After-hours26.09.24 06:208-KKey event#●●●#●●●
Santersus Bio
Xenetic Biosciences, Inc.
Xenetic Biosciences has entered into a definitive share exchange agreement to acquire Santersus AG. Upon closing, expected in the fourth quarter of 2026, the combined company will trade on Nasdaq under the ticker 'SNTS', with existing Xenetic shareholders owning approximately 15% and Santersus shareholders owning approximately 85% of the combined entity.…more
View filingShare
- 9.18Regular26.09.19 03:35SCHEDULE 13GOwnership
Santersus Bio
Xenetic Biosciences, Inc.
MJL Manager LLC has filed a Schedule 13G, reporting a beneficial ownership of more than 5% of Xenetic Biosciences, Inc. shares. This filing confirms the investor's significant stake in the company.…more
View filingShare - 9.16Pre-market26.09.16 20:008-KKey event
Santersus Bio
Xenetic Biosciences, Inc.
Xenetic Biosciences has entered into a definitive share exchange agreement to acquire Santersus AG as a wholly-owned subsidiary. Upon closing, existing Xenetic stockholders are expected to own approximately 15% of the combined company, which will be renamed Santersus Bio, Inc. and trade under the ticker symbol SNTS on Nasdaq. The transaction is subject to stockholder approval and customary closing conditions, with a potential termination fee of $500,000.…more
View filingShare
4 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.16Regular26.09.16 23:28Bullish#●●●#●●●#●●●
Xenetic Biosciences to Acquire Santersus and Rebrand
Xenetic Biosciences has entered a definitive agreement to acquire Santersus AG through an all-stock deal and will rebrand as Santersus Bio. The merger aims to combine their respective technologies to advance a clinical pipeline targeting neutrophil extracellular traps.…more
Detected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 9.16Pre-market26.09.16 20:25
●●●●●●●● ●●●●● ●●●●●●
Trading of Xenetic Biosciences (XBIO) shares was temporarily halted and subsequently resumed. This announcement reflects standard exchange procedures regarding trading status updates.…more
ShareBenzinga - 9.16Pre-market26.09.16 20:05
●●●●●●●● ●●●●● ●●●●●●
Xenetic Biosciences announced an all-stock acquisition of Santersus AG, resulting in significant share dilution for existing shareholders. The company will rebrand as Santersus Bio and trade under the ticker symbol SNTS.…more
ShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report